Cystic fibrosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
The prevention of airway infection with resistant bacterial pathogens (especially ''P. aeruginosa'') is essential. | The prevention of airway [[infection]] with resistant bacterial pathogens (especially ''[[Pseudomonas aeruginosa|P. aeruginosa]]'') is essential. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
*The prevention of airway infection with resistant bacterial pathogens (especially ''P. aeruginosa'') is essential.<ref name="pmid29303286">{{cite journal |vauthors=Fila L |title=[Cystic fibrosis in adults] |language=Czech |journal=Vnitr Lek |volume=63 |issue=11 |pages=834–842 |date= 2018 |pmid=29303286 |doi= |url=}}</ref> | *The prevention of airway [[infection]] with resistant bacterial pathogens (especially ''[[Pseudomonas aeruginosa|P. aeruginosa]]'') is essential.<ref name="pmid29303286">{{cite journal |vauthors=Fila L |title=[Cystic fibrosis in adults] |language=Czech |journal=Vnitr Lek |volume=63 |issue=11 |pages=834–842 |date= 2018 |pmid=29303286 |doi= |url=}}</ref> | ||
==References== | ==References== |
Revision as of 17:32, 2 March 2018
Cystic fibrosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cystic fibrosis secondary prevention On the Web |
American Roentgen Ray Society Images of Cystic fibrosis secondary prevention |
Risk calculators and risk factors for Cystic fibrosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
The prevention of airway infection with resistant bacterial pathogens (especially P. aeruginosa) is essential.
Secondary Prevention
- The prevention of airway infection with resistant bacterial pathogens (especially P. aeruginosa) is essential.[1]